- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Acute coronary syndrome
- Meeting Date: July 2024
- Public Summary Document (PSD) July 2024 PBAC Meeting - (PDF 456KB)
- Public Summary Document (PSD) July 2024 PBAC Meeting - (Word 74KB)
Prasugrel – July 2024
Prasugrel; Tablet 5 mg, Tablet 10 mg; Prasugrel SCP
Last updated
30 May 2025